Synucleinopathies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-01-07
Clinical Trial Update: Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease [Phase 2, Phase 3]
A Phase 2/3 trial of rasagiline for prodromal Parkinson disease, including REM sleep behavior disorder, has been withdrawn.